SPY
752.88
+0.10%
QQQ
682.55
+0.21%
BTC/USD
77,094.81
+0.55%
DIA
519.00
−0.07%
GLD
362.74
+0.30%
TLT
81.61
−0.15%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
CareDx Inc
CDNA
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$85.88
-1.53
-1.75%
Last update: Nov 2, 6:38 PM
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Options
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Earnings:
Q3 2026 Earnings were released on Thu Oct 29th, after the market close
Conference Call:
The most recent conference call started at 4:30 PM, 4 days ago
Click to view the webcast
CareDx Financials
CareDx (CDNA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
CareDx Raises FY26 Rev Guidance To $520M-$530M Prior $490M-$500M; Raises Adj. EBITDA Guidance To $90M-$100M Prior $66M-$78M
Benzinga Newsdesk
PRO
CareDx Raises FY2026 Sales Guidance from $490.000M-$500.000M to $520.000M-$530.000M vs $489.692M Est
CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $490.000 million-$500.000 million to $520.000 million-$530.000 million vs $489.692 million estimate.
Benzinga Newsdesk
PRO
CareDx Q3 Adj. EPS $0.70 Beats $0.25 Estimate, Sales $139.362M Beat $120.608M Estimate
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.25 by 180 percent. This is a 150 percent increase over earnings of $0.28 per share from the same period
Benzinga Newsdesk
PRO
CareDx Q2 Adj. EPS $0.37 Beats $0.23 Estimate, Sales $131.948M Beat $114.044M Estimate
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.23 by 60.87 percent. This is a 270 percent increase over earnings of $0.10 per share from the same
Benzinga Newsdesk
PRO
CareDx Raises FY2026 Sales Guidance from $447.000M-$465.000M to $490.000M-$500.000M vs $455.924M Est
CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $447.000 million-$465.000 million to $490.000 million-$500.000 million vs $455.924 million estimate.
Benzinga Newsdesk
PRO
CareDx Raises FY2026 Sales Guidance from $420.000M-$444.000M to $447.000M-$465.000M vs $436.665M Est
CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $420.000 million-$444.000 million to $447.000 million-$465.000 million vs $436.665 million estimate.
Benzinga Newsdesk
